NCT00001526View on ClinicalTrials.gov

ANTI-TAC THERAPY FOR UVEITIS

PHASE1CompletedINTERVENTIONAL

Enrollment

15

Participants

Timeline

Start Date

June 4, 1996

Study Completion Date

September 6, 2007

Conditions

Uveitis

Interventions

DRUG

Daclizumab (Zenapax)

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors

lead

National Eye Institute (NEI)

NIH

NCT00001526 - ANTI-TAC THERAPY FOR UVEITIS | Biotech Hunter | Biotech Hunter